Last updated: 2 September 2022 at 12:28pm EST

Evan Guillemin Net Worth




The estimated Net Worth of Evan Guillemin is at least $11.2 Million dollars as of 1 September 2022. Mr. Guillemin owns over 431 units of Mesa Laboratories stock worth over $3,492,281 and over the last 15 years he sold MLAB stock worth over $7,550,351. In addition, he makes $174,871 as Independent Director at Mesa Laboratories.

Mr. Guillemin MLAB stock SEC Form 4 insiders trading

Evan has made over 25 trades of the Mesa Laboratories stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 431 units of MLAB stock worth $51,535 on 1 September 2022.

The largest trade he's ever made was buying 40,000 units of Mesa Laboratories stock on 21 December 2010 worth over $990,000. On average, Evan trades about 3,446 units every 110 days since 2009. As of 1 September 2022 he still owns at least 29,207 units of Mesa Laboratories stock.

You can see the complete history of Mr. Guillemin stock trades at the bottom of the page.





Evan Guillemin biography

Evan C. Guillemin serves as Independent Director of the Company. Mr. Guillemin has served as Chief Financial Officer (“CFO”) and Associate Portfolio Manager at Select Equity Group Inc., a registered investment adviser based in New York City, since 2004. Mr. Guillemin also currently serves on the Board of Directors of Shake Shack, Inc. (NYSE: SHAK), and a privately held company. Prior to joining Select Equity Group, Mr. Guillemin served as CFO of Alloy Merchandising Group Inc., the successor to Delias Inc. Mr. Guillemin was an executive and board member of Delias Inc., a Nasdaq-traded specialty retailing company. He served as CFO and then Chief Operating Officer of Delias from 1996 to 2003, when the company was acquired by Alloy Inc. He received his Bachelor of Arts degree from Yale University in 1987 and a Master of Business Administration degree with distinction from Harvard Business School in 1996.

What is the salary of Evan Guillemin?

As the Independent Director of Mesa Laboratories, the total compensation of Evan Guillemin at Mesa Laboratories is $174,871. There are 9 executives at Mesa Laboratories getting paid more, with Gary Owens having the highest compensation of $3,485,970.



How old is Evan Guillemin?

Evan Guillemin is 54, he's been the Independent Director of Mesa Laboratories since 2009. There are 6 older and 8 younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories, Inc. is David Kelly, 78, who is the Independent Director.

What's Evan Guillemin's mailing address?

Evan's mailing address filed with the SEC is 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK, NY, 10003.

Insiders trading at Mesa Laboratories

Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny, and John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.



What does Mesa Laboratories do?

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers



What does Mesa Laboratories's logo look like?

Mesa Laboratories, Inc. logo

Complete history of Mr. Guillemin stock trades at Mesa Laboratories and Shake Shack Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
1 Sep 2022 Evan Guillemin
Director
Option 431 $178.42 $76,899
1 Sep 2022
29,207
18 Aug 2022 Evan Guillemin
Director
Sale 3,692 $196.12 $724,075
18 Aug 2022
28,776
15 Jun 2022 Evan Guillemin
Director
Option 30 $185.57 $5,567
15 Jun 2022
29,788
2 Dec 2021 Evan Guillemin
Director
Option 2,320 $91.57 $212,442
2 Dec 2021
32,078
15 Aug 2021 Evan Guillemin
Director
Option 308 $278.69 $85,837
15 Aug 2021
29,758
16 Jun 2021 Evan Guillemin
Director
Sale 720 $256.36 $184,579
16 Jun 2021
30,170
15 Jun 2021 Evan Guillemin
Director
Option 295 $263.30 $77,674
15 Jun 2021
30,890
17 May 2021 Evan Guillemin
Director
Sale 720 $244.25 $175,860
17 May 2021
30,595
16 Apr 2021 Evan Guillemin
Director
Sale 720 $253.77 $182,714
16 Apr 2021
31,315
16 Mar 2021 Evan Guillemin
Director
Sale 720 $269.48 $194,026
16 Mar 2021
32,035
16 Feb 2021 Evan Guillemin
Director
Sale 3,600 $281.52 $1,013,472
16 Feb 2021
32,755
15 Nov 2020 Evan Guillemin
Director
Option 477 $280.51 $133,803
15 Nov 2020
36,355
13 Nov 2020 Evan Guillemin
Director
Option 2,050 $41.80 $85,690
13 Nov 2020
37,928
12 Nov 2020 Evan Guillemin
Director
Option 950 $48.27 $45,857
12 Nov 2020
36,828
15 Jun 2020 Evan Guillemin
Director
Option 30 $226.72 $6,802
15 Jun 2020
35,878
16 Dec 2019 Evan Guillemin
Director
Sale 7,500 $251.31 $1,884,825
16 Dec 2019
40,848
7 Nov 2019 Evan Guillemin
Director
Option 150 $239.84 $35,976
7 Nov 2019
48,348
15 Jun 2019 Evan Guillemin
Director
Option 30 $202.39 $6,072
15 Jun 2019
48,198
20 Feb 2019 Evan Guillemin
Director
Option 1,746 $25.56 $44,628
20 Feb 2019
50,214
11 Feb 2019 Evan Guillemin
Director
Option 3,254 $17.68 $57,531
11 Feb 2019
51,722
4 Dec 2018 Evan Guillemin
Director
Sale 15,000 $212.72 $3,190,800
4 Dec 2018
48,468
3 Mar 2011 Evan Guillemin
Director
Buy 10,000 $29.00 $290,000
3 Mar 2011
200,000
21 Dec 2010 Evan Guillemin
Director
Buy 40,000 $24.75 $990,000
21 Dec 2010
190,000
12 Oct 2010 Evan Guillemin
Director
Buy 30,000 $21.52 $645,600
12 Oct 2010
150,000
30 Dec 2009 Evan Guillemin
Director
Buy 20,000 $23.10 $462,000
30 Dec 2009
120,000


Mesa Laboratories executives and stock owners

Mesa Laboratories executives and other stock owners filed with the SEC include: